Jove
Visualize
Contact Us

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
MicroRNAs01:22

MicroRNAs

3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
3.9K
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  2. Up-regulation Of Msmo1 Was Associated With Poor Survival In Cervical Cancer.
  1. Home
  2. Up-regulation Of Msmo1 Was Associated With Poor Survival In Cervical Cancer.

Related Experiment Video

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.6K

Up-regulation of MSMO1 was associated with poor survival in cervical cancer.

Jing Zou1, Sha Liu1, Jian Long1

  • 1Department of Oncology, Jingzhou Hospital, Yangtze University, Jingzhou, China.

Translational Cancer Research
|November 11, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

Methylsterol monooxygenase 1 (MSMO1) is elevated in cervical cancer and linked to poorer patient outcomes. This finding suggests MSMO1 may be a potential biomarker for cervical cancer progression and prognosis.

Keywords:
Methylsterol monooxygenase 1 (MSMO1)biomarkercervical cancerprognosissurvival

More Related Videos

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.7K
A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells
06:38

A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells

Published on: January 22, 2021

6.0K

Related Experiment Videos

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

2.6K
Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.7K
A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells
06:38

A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells

Published on: January 22, 2021

6.0K

Area of Science:

  • Biochemistry
  • Oncology
  • Molecular Biology

Background:

  • Methylsterol monooxygenase 1 (MSMO1) plays a role in cholesterol biosynthesis.
  • MSMO1 is implicated in the progression of various tumors.
  • The association between MSMO1 and cervical cancer remains unexplored.

Purpose of the Study:

  • To investigate the expression pattern of MSMO1 in cervical cancer.
  • To determine the correlation between MSMO1 expression and clinical characteristics in cervical cancer patients.

Main Methods:

  • Analysis of MSMO1 expression in 306 cervical cancer tissues and 13 non-tumor tissues.
  • Wilcoxon rank sum test for expression comparison.
  • Univariate and multivariate regression analyses for prognostic correlation.
  • Kaplan-Meier survival analysis.
  • Protein interaction and T cell infiltration analysis.
  • Main Results:

    • MSMO1 expression is significantly upregulated in cervical cancer tissues compared to non-tumor tissues (P<0.001).
    • Higher MSMO1 expression correlates with advanced disease stages (Stage III-IV) and incomplete treatment response (P=0.04, P<0.001).
    • Elevated MSMO1 is associated with significantly lower overall survival (OS), disease-specific survival (DSS), and progression-free survival (PFS) (P≤0.004).
    • High MSMO1 expression is identified as an independent risk factor for OS, DSS, and PFS in cervical squamous cell carcinoma (CESC) (HR > 1.9, P≤0.01).

    Conclusions:

    • MSMO1 is significantly overexpressed in cervical cancer.
    • Increased MSMO1 expression is correlated with adverse clinical characteristics and poor prognosis in CESC.
    • MSMO1 serves as a potential independent prognostic biomarker for cervical cancer.